Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 2157583, 9 pages
http://dx.doi.org/10.1155/2016/2157583
Review Article

Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings

Division of Endocrinology, Department of Clinical Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, SP, Brazil

Received 5 June 2016; Revised 18 August 2016; Accepted 15 September 2016

Academic Editor: Giuseppe Damante

Copyright © 2016 Arnaldo Moura Neto and Denise Engelbrecht Zantut-Wittmann. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Mebis and G. van den Berghe, “Thyroid axis function and dysfunction in critical illness,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 25, no. 5, pp. 745–757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Moura Neto, Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus [Ph.D. thesis], Universidade Estadual de Campinas, Sao Paulo, Brazil, 2016.
  3. U. M. Kabadi, “Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery,” The Journal of Clinical Endocrinology & Metabolism, vol. 59, no. 3, pp. 521–525, 1984. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Karadag, H. Ozcan, A. B. Karul, M. Yilmaz, and O. Cildag, “Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 101, no. 7, pp. 1439–1446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Vexiau, P. Perez-Castiglioni, G. Socie et al., “The ‘euthyroid sick syndrome’: incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation,” British Journal of Haematology, vol. 85, no. 4, pp. 778–782, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. M. O. Connell, D. C. Robbins, C. Bogardus, A. G. Burger, and E. Danforth Jr., “The interaction of free fatty acids in radioimmunoassays for reverse triiodothyronine. Radioimmunoassays for Reverse Triiodothyronine,” Journal of Clinical Endocrinology and Metabolism, vol. 55, no. 3, pp. 577–582, 1982. View at Google Scholar
  7. G. H. Elta, R. A. Sepersky, M. J. Goldberg, C. M. Connors, K. B. Miller, and M. M. Kaplan, “Increased incidence of hypothyroidism in primary biliary cirrhosis,” Digestive Diseases and Sciences, vol. 28, no. 11, pp. 971–975, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. L. A. Gavin, F. A. McMahon, J. N. Castle, and R. R. Cavalieri, “Alterations in serum thyroid hormones and thyroxine-binding globulin in patients with nephrosis,” The Journal of Clinical Endocrinology & Metabolism, vol. 46, no. 1, pp. 125–130, 1978. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Docter, E. P. Krenning, M. De Jong, and G. Hennemann, “The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism,” Clinical Endocrinology, vol. 39, no. 5, pp. 499–518, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. R. P. Peeters, P. J. Wouters, H. Van Toor, E. Kaptein, T. J. Visser, and G. Van Den Berghe, “Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4559–4565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. I. Surks, K. H. Hupart, C. Pan, and L. E. Shapiro, “Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis,” The Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 5, pp. 1031–1039, 1988. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Iervasi, A. Pingitore, P. Landi et al., “Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease,” Circulation, vol. 107, no. 5, pp. 708–713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Zoccali, F. Mallamaci, G. Tripepi, S. Cutrupi, and P. Pizzini, “Low triiodothyronine and survival in end-stage renal disease,” Kidney International, vol. 70, no. 3, pp. 523–528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. P. Peeters, P. J. Wouters, E. Kaptein, H. van Toor, T. J. Visser, and G. Van den Berghe, “Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 7, pp. 3202–3211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Rodriguez-Perez, F. Palos-Paz, E. Kaptein et al., “Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock,” Clinical Endocrinology, vol. 68, no. 5, pp. 821–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Mebis, L. Langouche, T. J. Visser, and G. Van Den Berghe, “Brief report: the type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3330–3333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Moura Neto, M. C. R. Parisi, M. A. Tambascia, S. M. Alegre, E. J. Pavin, and D. E. Zantut-Wittmann, “The influence of body mass index and low-grade systemic inflammation on thyroid hormone abnormalities in patients with type 2 diabetes,” Endocrine Journal, vol. 60, no. 7, pp. 877–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Boelen, J. Kwakkel, and E. Fliers, “Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection,” Endocrine Reviews, vol. 32, no. 5, pp. 670–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. F. Gardner, R. L. Carithers Jr., and R. D. Utiger, “Thyroid function tests in patients with acute and resolved hepatitis B virus infection,” Annals of Internal Medicine, vol. 96, no. 4, pp. 450–452, 1982. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Lambert, “7 Thyroid dysfunction in HIV infection,” Bailliere's Clinical Endocrinology and Metabolism, vol. 8, no. 4, pp. 825–835, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Borzio, R. Caldara, F. Borzio, V. Piepoli, P. Rampini, and C. Ferrari, “Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism,” Gut, vol. 24, no. 7, pp. 631–636, 1983. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Feelders, A. J. G. Swaak, J. A. Romijn et al., “Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients,” Metabolism: Clinical and Experimental, vol. 48, no. 3, pp. 324–329, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Boelen, M. C. Platvoet-Ter Schiphorst, and W. M. Wiersinga, “Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 6, pp. 1695–1699, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Wajner, I. M. Goemann, A. L. Bueno, P. R. Larsen, and A. L. Maia, “IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells,” Journal of Clinical Investigation, vol. 121, no. 5, pp. 1834–1845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. T. Nicoloff, D. A. Fisher, and M. D. Appleman Jr., “The role of glucocorticoids in the regulation of thyroid function in man,” The Journal of Clinical Investigation, vol. 49, no. 10, pp. 1922–1929, 1970. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Fliers, S. E. F. Guldenaar, W. M. Wiersinga, and D. F. Swaab, “Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 12, pp. 4032–4036, 1997. View at Google Scholar · View at Scopus
  27. V. S. Lim, C. Passo, Y. Murata, E. Ferrari, H. Nakamura, and S. Refetoff, “Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only,” Endocrinology, vol. 114, no. 1, pp. 280–286, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Fekete, B. Gereben, M. Doleschall et al., “Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome,” Endocrinology, vol. 145, no. 4, pp. 1649–1655, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Zeöld, M. Doleschall, M. C. Haffner et al., “Characterization of the nuclear factor-κB responsiveness of the human dio2 gene,” Endocrinology, vol. 147, no. 9, pp. 4419–4429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Moura Neto, M. C. R. Parisi, M. A. Tambascia, E. J. Pavin, S. M. Alegre, and D. E. Zantut-Wittmann, “Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes,” Endocrine, vol. 45, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. P. G. Curran and L. J. DeGroot, “The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland,” Endocrine Reviews, vol. 12, no. 2, pp. 135–150, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. W. M. Wiersinga, “Propranolol and thyroid hormone metabolism,” Thyroid, vol. 1, no. 3, pp. 273–277, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Bernardi, R. De Palma, F. Trevisani et al., “'Low T3 syndrome' in cirrhosis: effect of β-blockade,” American Journal of Gastroenterology, vol. 84, no. 7, pp. 727–731, 1989. View at Google Scholar · View at Scopus
  34. D. D. Ascheim and K. Hryniewicz, “Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state,” Thyroid, vol. 12, no. 6, pp. 511–515, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. D. Hein and I. M. D. Jackson, “Review: thyroid function in psychiatric illness,” General Hospital Psychiatry, vol. 12, no. 4, pp. 232–244, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. D. F. Gardner, M. M. Kaplan, C. A. Stanley, and R. D. Utiger, “Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation,” The New England Journal of Medicine, vol. 300, no. 11, pp. 579–584, 1979. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Wartofsky and K. D. Burman, “Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’,” Endocrine Reviews, vol. 3, no. 2, pp. 164–217, 1982. View at Publisher · View at Google Scholar · View at Scopus
  38. S. W. Spaulding, I. J. Chopra, R. S. Sherwin, and S. S. Lyall, “Effect of caloric restriction and dietary composition on serum T3 and reverse T3 in man,” The Journal of Clinical Endocrinology & Metabolism, vol. 42, no. 1, pp. 197–200, 1976. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Hennemann, R. Docter, and E. P. Krenning, “Causes and effects of the low T3 syndrome during caloric deprivation and non-thyroidal illness: an overview,” Acta Medica Austriaca, vol. 15, no. 1, pp. 42–45, 1988. View at Google Scholar · View at Scopus
  40. K. D. Burman, R. C. Smallridge, R. Osburne et al., “Nature of suppressed TSH secretion during undernutrition: effect of fasting and refeeding on TSH responses to prolonged TRH infusions,” Metabolism: Clinical and Experimental, vol. 29, no. 1, pp. 46–52, 1980. View at Publisher · View at Google Scholar · View at Scopus
  41. A. K. Suda, C. S. Pittman, T. Shimizu, and J. B. Chambers Jr., “The production and metabolism of 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine in normal and fasting subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 47, no. 6, pp. 1311–1319, 1978. View at Publisher · View at Google Scholar · View at Scopus
  42. G. C. Borst, R. C. Osburne, J. T. O'Brian, L. P. Georges, and K. D. Burman, “Fasting decreases thyrotropin responsiveness to thyrotropin-releasing hormone: a potential cause of misinterpretation of thyroid function tests in the critically ill,” The Journal of Clinical Endocrinology & Metabolism, vol. 57, no. 2, pp. 380–383, 1983. View at Publisher · View at Google Scholar · View at Scopus
  43. N. G. Blake, D. J. A. Eckland, O. J. F. Foster, and S. L. Lightman, “Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation,” Endocrinology, vol. 129, no. 5, pp. 2714–2718, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. E. A. Nillni, “Regulation of the hypothalamic Thyrotropin Releasing Hormone (TRH) neuron by neuronal and peripheral inputs,” Frontiers in Neuroendocrinology, vol. 31, no. 2, pp. 134–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Légràdi, C. H. Emerson, R. S. Ahima, J. S. Flier, and R. M. Lechan, “Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus,” Endocrinology, vol. 138, no. 6, pp. 2569–2576, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. J. L. Chan, K. Heist, A. M. DePaoli, J. D. Veldhuis, and C. S. Mantzoros, “The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men,” The Journal of Clinical Investigation, vol. 111, no. 9, pp. 1409–1421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Clément, C. Vaisse, N. Lahlou et al., “A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction,” Nature, vol. 392, no. 6674, pp. 398–401, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. E. M. De Vries, L. Eggels, H. C. Van Beeren et al., “Fasting-induced changes in hepatic thyroid hormone metabolism in male rats are independent of autonomic nervous input to the liver,” Endocrinology, vol. 155, no. 12, pp. 5033–5041, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Jain, G. Devpura, and B. S. Gupta, “Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults,” The Journal of the Association of Physicians of India, vol. 57, no. 7, pp. 508–510, 2009. View at Google Scholar · View at Scopus
  50. C. J. Hoffmann and T. T. Brown, “Thyroid function abnormalities in HIV-infected patients,” Clinical Infectious Diseases, vol. 45, no. 4, pp. 488–494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Ricarf-Engel, J. M. Fernández-Real, F. González-Huix, M. Del Pozo, J. Mascaró, and F. García-Bragado, “The relation between thyroid function and nutritional status in HIV-infected patients,” Clinical Endocrinology, vol. 44, no. 1, pp. 53–58, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. J. S. LoPresti, J. C. Fried, C. A. Spencer, and J. T. Nicoloff, “Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS),” Annals of Internal Medicine, vol. 110, no. 12, pp. 970–975, 1989. View at Publisher · View at Google Scholar · View at Scopus
  53. D. E. Sellmeyer and C. Grunfeld, “Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome,” Endocrine Reviews, vol. 17, no. 5, pp. 518–532, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Lambert, F. Zech, P. De Nayer, J. Jamez, and B. Vandercam, “Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection,” The American Journal of Medicine, vol. 89, no. 6, pp. 748–751, 1990. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Grunfeld, M. Pang, W. Doerrler et al., “Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome,” Metabolism: Clinical and Experimental, vol. 42, no. 10, pp. 1270–1276, 1993. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Madeddu, A. Spanu, F. Chessa et al., “Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study,” Clinical Endocrinology, vol. 64, no. 4, pp. 375–383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Olivieri, M. Sorcini, P. Battisti et al., “Thyroid hypofunction related with the progression of human immunodeficiency virus infection,” Journal of Endocrinological Investigation, vol. 16, no. 6, pp. 407–413, 1993. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Polikar, A. G. Burger, U. Scherrer, and P. Nicod, “The thyroid and the heart,” Circulation, vol. 87, no. 5, pp. 1435–1441, 1993. View at Publisher · View at Google Scholar · View at Scopus
  59. H. N. Pavlou, P. A. Kliridis, A. A. Panagiotopoulos, C. P. Goritsas, and P. J. Vassilakos, “Euthyroid sick syndrome in acute ischemic syndromes,” Angiology, vol. 53, no. 6, pp. 699–707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Opasich, F. Pacini, N. Ambrosino et al., “Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure,” European Heart Journal, vol. 17, no. 12, pp. 1860–1866, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. F. W. Holland II, P. S. Brown Jr., B. D. Weintraub, and R. E. Clark, “Cardiopulmonary bypass and thyroid function: a ‘euthyroid sick syndrome’,” The Annals of Thoracic Surgery, vol. 52, no. 1, pp. 46–50, 1991. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Iltumur, G. Olmez, Z. Ariturk, T. Taskesen, and N. Toprak, “Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome,” Critical Care, vol. 9, no. 4, pp. R416–R424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Vidart, S. M. Wajner, R. S. Leite et al., “N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 12, pp. 4537–4545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. N. R. Manowitz, G. H. Mayor, M. J. Klepper, and L. J. DeGroot, “Subclinical hypothyroidism and euthyroid sick syndrome in patients with moderate-to-severe congestive heart failure,” American Journal of Therapeutics, vol. 3, no. 12, pp. 797–801, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. E. M. Kaptein, “Thyroid hormone metabolism and thyroid diseases in chronic renal failure,” Endocrine Reviews, vol. 17, no. 1, pp. 45–63, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. M. R. Wiederkehr, J. Kalogiros, and R. Krapf, “Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 19, no. 5, pp. 1190–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Nicod, A. Burger, V. Staeheli, and M. B. Vallotton, “A radioimmunoassay for 3,3′,5′ triiodo-L-thyronine in unextracted serum: method and clinical results,” Journal of Clinical Endocrinology and Metabolism, vol. 42, no. 5, pp. 823–829, 1976. View at Publisher · View at Google Scholar · View at Scopus
  68. D. S. Silverberg, R. A. Ulan, D. M. Fawcett, J. B. Dossetor, M. Grace, and K. Bettcher, “Effects of chronic hemodialysis on thyroid function in chronic renal failure,” Canadian Medical Association Journal, vol. 109, no. 4, pp. 282–286, 1973. View at Google Scholar · View at Scopus
  69. K. Alsaran, A. Sabry, H. Alshahhat, E. Babgy, and F. Alzahrani, “Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: is there any difference?” Saudi Journal of Kidney Diseases and Transplantation, vol. 22, no. 5, pp. 917–921, 2011. View at Google Scholar · View at Scopus
  70. G. P. Bianchi, M. Zoli, G. Marchesini et al., “Thyroid gland size and function in patients with cirrhosis of the liver,” Liver, vol. 11, no. 2, pp. 71–77, 1991. View at Google Scholar · View at Scopus
  71. R. Malik and H. Hodgson, “The relationship between the thyroid gland and the liver,” Quarterly Journal of Medicine, vol. 95, no. 9, pp. 559–569, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Güven, F. Kelestimur, and M. Yücesoy, “Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy,” The European Journal of Medicine, vol. 2, no. 2, pp. 83–85, 1993. View at Google Scholar · View at Scopus
  73. G. C. Schussler, F. Schaffner, and F. Korn, “Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease,” The New England Journal of Medicine, vol. 299, no. 10, pp. 510–515, 1978. View at Publisher · View at Google Scholar · View at Scopus
  74. A. R. Hill, M. F. J. Schmidt, and G. C. Schussler, “Rapid changes in thyroid function tests upon treatment of tuberculosis,” Tubercle and Lung Disease, vol. 76, no. 3, pp. 223–229, 1995. View at Publisher · View at Google Scholar · View at Scopus
  75. J. L. Schlienger, A. Anceau, G. Chabrier, M. L. North, and F. Stephan, “Effect of diabetic control on the level of circulating thyroid hormones,” Diabetologia, vol. 22, no. 6, pp. 486–488, 1982. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Radetti, F. Drei, F. Franzellin, B. Pasquino, and G. Mengarda, “Thyroid function in type 1 juvenile diabetes mellitus: tendency to the low T3 syndrome,” Helvetica Paediatrica Acta, vol. 40, no. 6, pp. 461–466, 1985. View at Google Scholar
  77. H. Dorchy, P. Bourdoux, and B. Lemiere, “Subclinical thyroid hormone abnormalities in type I diabetic children and adolescents. Relationship to metabolic control,” Acta Paediatrica Scandinavica, vol. 74, no. 3, pp. 386–389, 1985. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Tahirović, V. Dućić, and A. Smajić, “Euthyroid sick syndrome in type I diabetes mellitus in children and adolescents,” Acta Paediatrica Hungarica, vol. 31, no. 1, pp. 67–73, 1991. View at Google Scholar · View at Scopus
  79. A. Moura Neto, M. C. R. Parisi, S. M. Alegre, E. J. Pavin, M. A. Tambascia, and D. E. Zantut-Wittmann, “Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus,” Endocrine, vol. 51, no. 1, pp. 63–71, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. J. M. Dora, W. E. Machado, J. Rheinheimer, D. Crispim, and A. L. Maia, “Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis,” European Journal of Endocrinology, vol. 163, no. 3, pp. 427–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Marsili, C. Aguayo-Mazzucato, T. Chen et al., “Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity,” PLoS ONE, vol. 6, no. 6, Article ID e20832, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Karlović, S. Marušić, and M. Martinac, “Increase of serum triiodothyronine concentration in soldiers with combat-related chronic post-traumatic stress disorder with or without alcohol dependence,” Wiener Klinische Wochenschrift, vol. 116, no. 11-12 A, pp. 385–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Nader, M. D. Warner, S. Doyle, and C. A. Peabody, “Euthyroid sick syndrome in psychiatric inpatients,” Biological Psychiatry, vol. 40, no. 12, pp. 1288–1293, 1996. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Duval, M.-C. Mokrani, J. A. Monreal-Ortiz et al., “Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates,” Psychoneuroendocrinology, vol. 31, no. 7, pp. 876–888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Arem and K. Cusi, “Thyroid function testing in psychiatric illness: usefulness and limitations,” Trends in Endocrinology and Metabolism, vol. 8, no. 7, pp. 282–287, 1997. View at Publisher · View at Google Scholar · View at Scopus
  86. C. G. Acker, A. R. Singh, R. P. Flick, J. Bernardini, A. Greenberg, and J. P. Johnson, “A trial of thyroxine in acute renal failure,” Kidney International, vol. 57, no. 1, pp. 293–298, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. J. D. Klemperer, I. Klein, M. Gomez et al., “Thyroid hormone treatment after coronary-artery bypass surgery,” The New England Journal of Medicine, vol. 333, no. 23, pp. 1522–1527, 1995. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Pingitore, E. Galli, A. Barison et al., “Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: A Randomized, Placebo-Controlled Study,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 4, pp. 1351–1358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. G. A. Brent and J. M. Hershman, “Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration,” Journal of Clinical Endocrinology & Metabolism, vol. 63, no. 1, pp. 1–8, 1986. View at Publisher · View at Google Scholar · View at Scopus
  90. L. J. D. Groot, “Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies,” Critical Care Clinics, vol. 22, no. 1, pp. 57–86, 2006. View at Publisher · View at Google Scholar · View at Scopus